1. Home
  2. List
Reference Patent

Reference - List

  • 31 Hits
  • Search Condition : Filter (MeSH = Neoplasms / immunology*)
Species Resource Title
Human and Animal Cells HSC-4(RCB1902) , KP4(RCB1015) SSTP1, a Host Defense Peptide, Exploits the Immunomodulatory IL6 Pathway to Induce Apoptosis in Cancer Cells.
Human and Animal Cells OV2944-HM-1(RCB1483) Anti‑VEGF antibody triggers the effect of anti‑PD‑L1 antibody in PD‑L1low and immune desert‑like mouse tumors.
Human and Animal Cells THP-1(RCB1189) , LLC(RCB0558) Zn- and Mg- containing tricalcium phosphates-based adjuvants for cancer immunotherapy.
Human and Animal Cells NIH3T3-3-4(RCB1862) Reversion analysis reveals the in vivo immunogenicity of a poorly MHC I-binding cancer neoepitope.
Human and Animal Cells EBC-1(RCB1965) A stealth antigen SPESP1, which is epigenetically silenced in tumors, is a suitable target for cancer immunotherapy.
Human and Animal Cells C2C12(RCB0987) , B16F10(RCB2630) Extracellular acidity in tumor tissue upregulates programmed cell death protein 1 expression on tumor cells via proton-sensing G protein-coupled receptors.
Human and Animal Cells LLC(RCB0558) , YAC-1 , Colon-26(RCB2657) , L929(RCB1451) PolyI:C-Induced, TLR3/RIP3-Dependent Necroptosis Backs Up Immune Effector-Mediated Tumor Elimination In Vivo.
Human and Animal Cells NIH3T3-3-4(RCB1862) Chondroitin Sulfate-Based pH-Sensitive Polymer-Modified Liposomes for Intracellular Antigen Delivery and Induction of Cancer Immunity.
Human and Animal Cells Hep G2(RCB1886) Generation of Rat Monoclonal Antibody for Human IQGAP1 by Immunization of Three-Dimensional-Cultured Cancer Cells.
Human and Animal Cells K562 Improvement of QOL and Immunological Function With Lentinula Edodes Mycelia in Patients Undergoing Cancer Immunotherapy: An Open Pilot Study.
Human and Animal Cells B16F10(RCB2630) Circulating nano-particulate TLR9 agonist scouts out tumor microenvironment to release immunogenic dead tumor cells.
Human and Animal Cells OP9-DLL1 Derivation of mimetic γδ T cells endowed with cancer recognition receptors from reprogrammed γδ T cell.
Human and Animal Cells MOLT-4(RCB0206), Jurkat, RPMI8226(RCB3010) Development of a protein-based system for transient epigenetic repression of immune checkpoint molecule and enhancement of antitumour activity of natural killer cells.
Human and Animal Cells LM8(RCB1450) , Saos-2(RCB0428) , HOS(RCB0992), , 143B/TK^(-)neo^(R)(RCB0701) Anti-PD-1 antibody decreases tumour-infiltrating regulatory T cells.
Human and Animal Cells Hepa 1-6(RCB1638) , YAC-1 Everolimus enhances TRAIL-mediated anti-tumor activity of liver resident natural killer cells in mice.
Human and Animal Cells HeLa(RCB0007) Propagermanium Induces NK Cell Maturation and Tends to Prolong Overall Survival of Patients With Refractory Cancer.
Human and Animal Cells K562 Histidine-rich glycoprotein augments natural killer cell function by modulating PD-1 expression via CLEC-1B.
Human and Animal Cells EL4(RCB1641) Novel chemical compound SINCRO with dual function in STING-type I interferon and tumor cell death pathways.
Mice RBRC02975 Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells.
Human and Animal Cells PC-9(RCB4455) Effect of IL-18 on the Expansion and Phenotype of Human Natural Killer Cells: Application to Cancer Immunotherapy.